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Protein aggregation is a complex process resulting in the formation of heterogeneous mix-
tures of aggregate populations that are closely linked to neurodegenerative conditions, such
as Alzheimer’s disease. Here, we find that soluble aggregates formed at different stages of
the aggregation process of amyloid beta (Aβ42) induce the disruption of lipid bilayers and
an inflammatory response to different extents. Further, by using gradient ultracentrifugation
assay, we show that the smaller aggregates are those most potent at inducing membrane
permeability and most effectively inhibited by antibodies binding to the C-terminal region
of Aβ42. By contrast, we find that the larger soluble aggregates are those most effective
at causing an inflammatory response in microglia cells and more effectively inhibited by
antibodies targeting the N-terminal region of Aβ42. These findings suggest that different
toxic mechanisms driven by different soluble aggregated species of Aβ42 may contribute to
the onset and progression of Alzheimer’s disease.
https://doi.org/10.1038/s41467-019-09477-3 OPEN
1 Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK. 2 Centre for Misfolding Diseases, Department of Chemistry,
University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK. 3 Department of Veterinary Medicine, University of Cambridge, Madingley Road,
Cambridge CB3 0ES, UK. 4 Cavendish Laboratory, University of Cambridge, J J Thomson Avenue, Cambridge CB3 1HE, UK. 5 UK Dementia Research Institute,
University of Cambridge, Cambridge CB2 0XY, UK. These authors contributed equally: Suman De, David C. Wirthensohn, Patrick Flagmeier, Craig Hughes,
Francesco A. Aprile, Francesco S. Ruggeri. Correspondence and requests for materials should be addressed to S.D. (email: sd730@cam.ac.uk)
or to M.V. (email: mv245@cam.ac.uk) or to D.K. (email: dk10012@cam.ac.uk)
NATURE COMMUNICATIONS |         (2019) 10:1541 | https://doi.org/10.1038/s41467-019-09477-3 | www.nature.com/naturecommunications 1
12
34
56
78
9
0
()
:,;
Many human pathologies, including neurodegenerativedisorders such as Alzheimer’s disease (AD), areassociated with the aggregation of amyloidogenic
proteins1,2. In AD, the normally soluble amyloid beta peptide
(Aβ) forms insoluble deposits in the brains of affected
individuals3,4. The molecular mechanism that governs the
aggregation of Aβ involves the formation of a variety of soluble
oligomeric intermediates of different sizes and structures5,6. It has
been shown that these soluble oligomeric species play a critical
role in the cascade of events that ultimately leads to AD via a
wide range of neurotoxic events, including the permeabilization
of cellular membranes, calcium dysregulation, mitochondrial
damage, induction of inflammation, and oxidative stress7–11.
The soluble oligomeric aggregates formed during the process of
amyloid formation are typically highly heterogeneous, and exist
in a variety of sizes, shapes and structures, with different degrees
of β-sheet content and surface hydrophobicity11,12. These dif-
ferences could give rise to variations in both the mechanism and
degree of cytotoxicity. It is therefore important to characterize
the structural differences between different soluble aggregates
formed over the course of the aggregation reaction and to
determine how specific structural features are related to toxicity
and could contribute to disease pathogenesis. These soluble
aggregates populated during the aggregation of Aβ in particular
have been shown to be low in abundance and heterogeneous in
both size and conformation, making it challenging to characterize
their structure and mechanism of toxicity13. In this context, a
recent advance has been the design and generation of rationally
designed antibodies that recognize specific epitopes of Aβ and
inhibit its aggregation14,15. The binding of such antibodies to Aβ
aggregates provides information about the accessibility of specific
epitopes, and have been found to inhibit aggregate-induced
toxicity11. Thus, the systematic targeting of soluble aggregates
of Aβ with designed antibodies should allow us to determine
the accessibility and significance of individual regions of the Aβ
sequence in generating aggregate-induced toxicity.
Given the heterogeneous nature of these soluble aggregates, we
use a previously described gradient ultracentrifugation method
that allows oligomeric species formed in an aggregation reaction
to be separated on the basis of their size and density16–18. We
study the aggregation of Aβ42, the 42-residue isoform of Aβ, and
monitor the toxicity for aggregates of different sizes in the pre-
sence of the designed antibodies that target distinct epitopes. Two
ultrasensitive methods able to measure well-defined effects of the
aggregates are used. The first is a quantitative assay that deter-
mines the ability of the protein aggregates to induce the per-
meabilization of lipid bilayers and the second is an assay that
measures the ability of aggregates to induce inflammation
through the measurement of cytokine production by microglial
cells. We observe a relatively decreased ability of the oligomers to
disrupt lipid bilayers and a relatively increased capability to cause
inflammation as the size of the Aβ42 aggregates increased. We
then find that these effects correlate with changes in the surface
structure of the aggregates as indicated by differences in the
effects of the designed antibodies.
Results
Different Aβ42 aggregates have distinct toxicity mechanisms.
To test quantitatively the level of lipid membrane permeability
induced by soluble Aβ42 aggregates formed at different stages
of the aggregation reaction (Fig. 1a), we used a recently developed
high-throughput assay based on the measurement of changes
in the localized fluorescence intensity of individual nano-sized
lipid vesicles19. We immobilized thousands of individual vesicles
onto glass cover slides, which act as individual nano-reactors,
each containing a reporter of the presence of calcium ions
(Ca2+) that enter into the vesicle, the quantity of which can
be measured using total internal reflection fluorescence (TIRF)
microscopy19–22 (Fig. 1b). We have previously shown that
monomeric Aβ42 does not induce membrane permeability and
that soluble aggregates rather than mature fibrils are the species
responsible for inducing this membrane disruption and ion
influx19. For this study, we aggregated monomeric Aβ42 at a
concentration of 2 µM under quiescent conditions and removed
aliquots from the solution at different time points. Using
this assay, we found that aliquots taken at an early time point
(15 min) in the aggregation reaction, when diluted to a con-
centration of 50 nM, induced twice as much Ca2+ influx com-
pared to aggregates present in the aliquots taken at later stages
(30 min) of the aggregation reaction (Fig. 1b, c).
By contrast, we observed an opposite trend in the effects of
soluble Aβ42 aggregates when monitored by an inflammation
assay. Inflammation is driven by pattern recognition receptors,
such as toll-like receptors (TLRs)23,24. Multiple studies have
demonstrated that soluble forms of Aβ interact with the toll-like
receptor 4 (TLR4) on microglia cells, resulting in the production
of inflammatory cytokines that are thought to contribute to
the neuronal damage associated with the progression of AD24–27.
To study and quantify the inflammation induced in cells by the
Aβ42 protein aggregates, we monitored the levels of secreted
tumour necrosis factor alpha (TNF-ɑ), a pro-inflammatory
cytokine, using an enzyme-linked immunosorbent assay (ELISA)
assay28 (Fig. 1d). We took aliquots from the same aggregation
reaction of Aβ42 as described above, diluted them to monomer-
equivalent concentrations of 1 µM, added the samples to BV2
microglia cells, and incubated for 24 h before measuring the
cumulative TNF-α production from the supernatant, using
the ELISA assay. We found that addition of the aliquots of the
Aβ42 aggregation reaction mixture did indeed activate an innate
immune response through the production of significant amounts
of TNF-α; by contrast, addition of samples containing monomeric
or fibrillar forms of Aβ42 did not cause any significant
inflammatory response (Supplementary Fig. 1a). We also
observed that the inflammatory response for the oligomeric
aggregates could be effectively blocked with 100 ng/mL of the
TLR4 antagonist Rhodobacter sphaeroides lipid A (RSLA)
(Supplementary Fig. 1b), indicating that TLR4 signalling plays a
dominant role in the observed response. We observed that
aggregates present in aliquots removed at the later stage (30 min)
in the Aβ42 aggregation process induce a stronger inflammatory
response than the aggregates present in the aliquots taken at the
early stage (15 min) of the aggregation reaction (Fig. 1e).
Size and toxicity mechanism of Aβ42 aggregates are linked.
The differences between the species of Aβ42 in the aliquots taken
from the aggregation reaction at different times in the two toxi-
city assays used in this work could be due to differences in the size
and structure of aggregates since both of these properties change
over the course of the aggregation reaction. To test this hypoth-
esis, we employed a sucrose gradient ultracentrifugation techni-
que by means of which protein aggregates of different sizes can be
separated into distinct fractions13,16,18. Therefore, we combined
in equal proportions aggregates taken from three different time
points during the aggregation reaction; (i) the end of the lag
phase, (ii) the middle of the growth phase and (iii) in the plateau
phase (Fig. 2a). This mixture was injected over a sucrose gradient
prepared by adding 600 μL of 10%, 20%, 30%, 40% and 50% (w/v)
sucrose solutions from top to bottom in a rotor tube and ultra-
centrifugation was performed (Fig. 2b). This technique allowed us
to separate the soluble aggregates of Aβ42 into different fractions,
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based on their mass, for testing in two toxicity assays. We found
that the aggregates present in the 20% sucrose solution induced
Ca2+ influx most effectively (Fig. 2c), and that those present in
the 30% fraction were most effective at inducing an inflammatory
response (Fig. 2d). The supernatant, pallets and sucrose do not
induce any inflammatory response or membrane permeation
(Supplementary Fig. 2).
To characterize the aggregates present in the 20% and 30%
sucrose solutions, we used high-resolution and phase-controlled
atomic force microscopy (AFM) to acquire 3D images of the
aggregates within each fraction with sub-nanometre resolution29.
Remarkably, this approach is capable to acquire the morphology
of biomolecules as small as low molecular weight monomers
(Aβ42, ~4 kDa)30. Then, by means of statistical analysis of the
cross-sectional dimensions of the species in the individual
images31, is capable to distinguish monomers from the early
oligomeric aggregated species, a capability that is at the limit of
any existing biophysical single-molecule method. In Fig. 3a–e,
we show typical 3d morphology maps of the 10%, 20%, 30%,
40% and 50% fractions (left panels) along with high-resolution
images of typical species present in each fraction (central panel)
with the relative cross-sectional height (right panel). In the right
column of Fig. 3 we show that the results of the statistical analysis
of the cross-sectional dimensions of the aggregates within each
fraction. While the measurement of the cross-sectional height of
the aggregates can be measured with angstrom resolution, the
measurement of cross-sectional diameters is limited by the AFM
tip size and the consequent convolution effects32; we therefore
used an established approach to obtain de-convolved cross-
sectional diameters of the aggregates33,34 (see Methods for
details). The results showed a significant increase in the average
height of the aggregates as a function of the sucrose fraction
density (Fig. 4a); an increase in the cross-sectional diameter was
also visible for the 40% and 50% fractions (Fig. 4b). The smallest
observed cross-sectional height (0.3–0.5 nm) in all the fractions
corresponded to the size of the monomeric protein. The average
level of noise is well below 0.1 nm and the signal to noise ratio
for measuring a single monomer is approximately 10, which
allows the accurate determination of cross-sectional height of
individual aggregate (Supplementary Fig. 3). The 10% and 20%
fractions showed a high abundance of both monomeric and
approximately spherical oligomeric species (the latter with
heights of 0.5–2 nm)31,34. The 30% sucrose fraction showed a
smaller number of monomeric species and the presence of both
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Fig. 1 Soluble Aβ42 aggregates at different aggregation stages show different toxicity mechanisms. a The aggregation Aβ42 was monitored by ThT
fluorescence. Each data point represents the mean of three independent biological repeats and its error bar the corresponding standard deviation. Aliquots
containing Aβ42 aggregates were taken from the aggregation reaction at two different time points—at the end of the lag phase (15 min, for ‘early’ soluble
aggregates) and at the midpoint of the growth phase (30min, for ‘late’ soluble aggregates). b The lipid bilayer permeability induced by Aβ42 aggregates
was measured by immobilizing on glass cover slides hundreds of nano-sized individual lipid vesicles in the presence of a Ca2+-sensitive dye. If the
aggregates disrupt the integrity of the lipid bilayer, Ca2+ from the external medium enters into individual vesicles to a level that can be quantified using
highly sensitive total internal fluorescence microscopy (TIRF) measurements. c Early Aβ42 aggregates cause a higher level of bilayer permeability than
later Aβ42 aggregates. The data were averaged over three biological repeats, with each repeat involving the analysis of 6000 individual lipid vesicles, the
error bars represent standard deviation, and the statistical significance was calculated using a two-sample t-test. d The inflammatory response in microglia
was quantified using an ELISA assay to measure the levels of secreted tumour necrosis factor alpha (TNF-ɑ). e In contrast to the bilayer permeability assay,
the late aggregates were more effective than the early aggregates. The data are averaged over three biological repeats, each repeat was averaged over
three wells, each of which contained 200,000 to 300,000 BV2 cells, the error bars represent the standard deviation among the repeats, and the statistical
significance was calculated using a two-sample t-test (unpaired). Data points for each biological replicate shown with red circles. Source data of a, c and
e are provided as Source Data files. Aggregates used for the membrane permeability and the inflammation assays were collected from the same
aggregation reaction
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spherical oligomers and more elongated filamentous species, the
latter being identified as protofilaments with a mean height of
0.4–1 nm31 and a length of several hundred nm. The 30% sucrose
fraction, showing the highest increase in TNFα levels, was the
only one in which such protofilaments were visible. The fractions
at higher percentages of sucrose, 40% and 50%, showed only
higher order aggregates.
We then characterized the structures of the individual
aggregates present in different sucrose fractions using a single-
particle Förster resonance energy transfer (FRET) approach35,36.
First, we generated co-aggregates from the 1:1 molar ratio of
Aβ42 by aggregating monomers labelled with FRET donors and
FRET acceptors (Fig. 5a, b). This approach allowed us to define
the relative aggregate sizes and their FRET efficiencies as
described previously37–39. We observed a gradual increase in
the FRET efficiency with increasing aggregate size, which is
indicative that the donors and acceptors are increasingly close
together in the larger oligomers (Fig. 5c and Supplementary
Fig. 4). Second, we used total internal reflection (TIRF)
microscopy to observe the aggregates both with the FRET
samples and using extrinsically fluorescent dyes such as
thioflavin-T (ThT) and pFTAA (Fig. 5d and Supplementary
Fig. 5)40,41. This strategy allowed us to determine the fluorescence
intensities of individual aggregates, and the data show a gradual
increase in mean intensity from low to high sucrose fractions
(Fig. 5e, f), i.e. with an increase in aggregate size. This approach
was particularly useful for sub-diffraction sized aggregates that
appear to have similar diameters but to differ in fluorescence
intensity, while in the higher density sucrose fractions the
morphology of the fluorescence spots was observed to change
from diffraction limited points to elongated fibrils.
In combination these data show that the smaller aggregates
present in low sucrose density solutions are on average more
potent at membrane permeation than the relatively larger
aggregates present in high sucrose density solutions. Since the
ability of protein aggregates to permeabilise lipid membrane can
be correlated with their surface hydrophobicity, we have
performed an advanced spectrally resolved super-resolution
imaging to map the surface hydrophobicity of soluble Aβ42
aggregates at the single-aggregate level42,43. We used a solvato-
chromic dye, Nile Red, which transiently binds to protein
aggregates and whose emission spectra is sensitive to the local
hydrophobicity42,43. We compared the average of the mean
emission maxima from individual aggregates and found that the
20% faction was more hydrophobic than the aggregates present at
higher sucrose fractions (Supplementary Fig. 6) with a blueshift of
approximately 10 nm compared to the aggregate present at 30%
and 40% sucrose fraction. This observation is consistent with
previous observations that the ability to permeabilize membranes
is higher for small aggregates than for larger ones, and is
enhanced by the increased exposure of hydrophobic patches44,45.
In addition, the small soluble species present at early stages of the
aggregation process have been reported to have higher tendencies
to interact, permeabilize and cross the plasma membrane than
larger aggregates44. Interestingly, the larger aggregates, which
appear elongated and similar to descriptions of protofilaments31,
that are present in 30% sucrose solution were found to be more
effective at inducing inflammation.
Roles of Aβ42 sequence regions in the toxicity mechanisms. We
next used a panel of single-domain antibodies to probe the
regions of the Aβ42 peptide that are important for generating the
membrane permeability and inflammatory response induced by
the different oligomeric aggregates. We employed five rationally
designed antibodies (DesAbs) that target five different linear
epitopes on Aβ42 that effectively scan its whole sequence15. In
particular, the third complementary-determining region (CDR3)
of antibody DesAb3–9 was grafted with a sequence (HETLTLR),
which is designed to bind to the N-terminal region of Aβ42. The
antibodies DesAb13–19 (CDR3: LSVIKEI) and DesAb18–24
(CDR3: VFVGTEA) were designed to bind to the central region
of Aβ42, and the antibodies DesAb29–36 (CDR3: GSMYKATV)
and DesAb36–42 (CDR3: LGIKAEL) were designed to target its
C-terminal region of (Fig. 6a). These DesAbs have been found
to bind with much higher affinity to aggregates of Aβ42 than to
the corresponding monomeric species13.
We first assessed the ability of the designed antibodies to
inhibit the Aβ42 aggregate-induced membrane permeability.
Different concentrations of the DesAbs were added to aliquots
of the solutions from the aggregation reaction described above
containing the differently sized species present in the 20% and
30% sucrose fractions. We first measured the ability of these
species to disrupt lipid membranes by measuring the extent of
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Fig. 2 Aβ42 aggregates of diverse sizes exhibit different relative toxicity by
distinct mechanisms. a Aβ42 aggregation monitored by ThT fluorescence.
Soluble aggregates formed at different time points were mixed together and
separated via a discontinuous sucrose gradient. Three different time points
during the aggregation of 2 µM Aβ42 in SSPE buffer at 37 °C were chosen:
(i) At the end of the lag phase (15 min), (ii) at the middle of growth phase
(30min) and (iii) during the plateau phase (60min). b Aliquots collected at
these time points were loaded in a step gradient of 10% to 50% sucrose
and ultracentrifuged and the fractions were collected immediately and
stored. The sizes of the aggregates present within different densities of
the sucrose solution increase with the sucrose density. c The lipid bilayer
permeability assay shows that aggregates present at 20% sucrose are
the most potent at membrane permeation. d Aggregates presents at 30%
sucrose are the most effective at inducing inflammation. These experiments
were carried out for two independent aggregation reactions of Aβ42
(n= 2) and the error bars represent the standard deviation of the mean
for each field of view (for 2C) and for each well (2D). Source data of
a, c and d are provided as a Source Data file
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Ca2+ influx into the tethered vesicles (Fig. 6b, c). We observed
that all the DesAbs reduced the aggregate-induced membrane
permeability, and that the ability to do so increased progressively
as the epitope on Aβ42 varied from the N-terminal to the C-
terminal region. Indeed, DesAb36–42, which binds to the most C-
terminal region of Aβ42, was found to be the most effective
antibody in suppressing the induction of bilayer permeability.
This result suggests that the hydrophobic C-terminal region of
Aβ42 is directly involved in the mechanism by which perme-
ability occurs. The concentration required for all the antibodies,
including DesAb36–42, to reduce the Ca2+ influx by 50% was
similar for the aliquots taken from both the 20% and 30% sucrose
fractions, suggesting that the structural characteristics enabling
the aggregates to induce bilayer permeability are not significantly
affected by their overall size. In addition single-particle imaging
measurements of the populations of Aβ42 aggregates able to
bind to ThT-active species41 showed no significant difference in
the number of such species detected before and after incubation
with the antibodies, indicating that none of the panel of
antibodies disrupted the aggregates detectably within the time
frame of our experiments (Supplementary Fig. 7).
We next examined the ability of the same panel of antibodies
on the inflammation induced by Aβ42 aggregates. The aggregates
contained in the 20% and 30% sucrose fractions were incubated
with varying concentrations of each antibody, and then added to
BV2 microglial cells. Although addition of antibodies resulted
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Fig. 3 AFM characterization of aggregates present in sucrose fractions. a–e Representative AFM images of the Aβ42 aggregates present at different
fractions of sucrose gradient (left panels), with a magnified example of the species present in each fraction (central panel) and the corresponding cross-
sectional dimensions (right panel). The 30% fraction (c) is the only one that shows protofilaments aggregates
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-09477-3 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:1541 | https://doi.org/10.1038/s41467-019-09477-3 | www.nature.com/naturecommunications 5
in a decrease in TNF-α expression, we observed that much higher
concentrations of antibodies were needed to reduce inflammation
than to decrease lipid permeability. Moreover, in contrast to
the observation that the inhibition of bilayer permeability was
greatest with the antibody DesAb36–42, the most significant
reduction in the levels of TNF-α expression was found with the
antibody DesAb3–9, which binds close to the N-terminus of
the peptide. We also observed a general decrease in the efficacy
of the antibodies as the binding epitope is moved closer to the
C-terminal region of Aβ42 (Fig. 6d, e). As with the permeability
assay, we observed the same fractional reduction in TNF-α
production with each antibody for aggregates of different sizes,
showing that the regions of the aggregates responsible for
inducing inflammation are structurally accessible in the same
way in the larger and smaller species. It has to be noted that these
antibodies do not induce any significant membrane permeation
or inflammation (Supplementary Fig. 2).
Discussion
We have shown that soluble Aβ42 aggregates of different sizes
vary in their relative contributions to different mechanisms of
toxicity, namely the induction of membrane permeability and of
inflammation. The smaller aggregates formed at an early stage
of the aggregation process of Aβ42 were observed to be more
effective at inducing permeability of lipid bilayers, whereas larger
aggregates formed at a later stage of the aggregation reaction
were more potent at inducing an inflammatory response. Using
rationally designed single-domain antibodies, we employed an
epitope scanning technique to determine which regions of the
sequence of Aβ42 are most solvent accessible in the two types
of aggregates. We observed that all the antibodies inhibited both
types of toxicity but that those that bind to the C-terminal region
of Aβ42 were more effective in counteracting the induction
of bilayer permeability than the antibodies that bind to the
N-terminal region. We observed an opposite trend, however, for
the inhibition of aggregate-induced inflammation in microglia
cells, where antibodies designed to bind to the N-terminal region
of the sequence were more effective. These differences are likely
to be due to the favourable accessibility of solvent exposed
N-terminal segments in the larger aggregates of Aβ42 that are
formed at later stages of the aggregation process.
The structures of Aβ42 fibrils determined using cryo-electron
microscopy and nuclear magnetic resonance spectroscopy show
that the N-terminal residues are substantially exposed within the
assemblies, whereas the C-terminal residues are largely located
within the hydrophobic core of the cross-β structure46,47.
Our observation that DesAb3–9, which binds to the N-terminal
region, is the most effective in counteracting the toxicity of the
various Aβ42 aggregates indicates that this region is similarly
exposed in the soluble oligomeric aggregate structures47, and
indeed that the N-terminal residues are important for TLR
signalling and hence for inflammation23. Moreover, larger pro-
tofibrils or protofilaments are likely to present an increased
number of TLR4 binding sites on their surfaces, the majority of
which are likely to need to interact with the antibodies to block
signalling. This scenario would provide an explanation of why
much higher concentrations of designed antibodies were found
to be needed to reduce the inflammatory response than for
suppressing the degree of bilayer permeability experiments.
Moreover, the ability of the antibodies that bind to the C-terminal
region to counter the bilayer permeability, which is induced
most effectively by the smaller Aβ42 aggregates, suggests that
the hydrophobic C-terminal region of these oligomeric species
is exposed in this species, and responsible for the observed dis-
ruption of the lipid bilayer.
Our results show that structurally different aggregated species
exist within the heterogeneous ensemble of soluble Aβ42 aggre-
gates and that these can exert toxicity by distinct mechanisms.
As the aggregation process proceeds, and the Aβ42 aggregates
on average increase in size and undergo structural changes, as
we have previously observed with α-synuclein39,48, their ability
to disrupt the integrity of lipid bilayers of the type involved in
cellular membranes appears to be reduced relative to triggering
an inflammatory response. These results suggest that different
aggregated forms of Aβ42 may differ in their contributions to
different mechanisms of toxicity that develop during the pro-
gression of AD and other misfolding disorders associate with Aβ
self-assembly. We therefore anticipate that effective strategies
aimed at targeting pathogenic Aβ42 species formed during
the progression of disease may involve the use of cocktails of
therapeutic agents targeting the diversity of species that are
populated during the aggregation process.
Methods
Purification and aggregation of synthetic Aβ42. The Aβ42 peptide
(DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA) (Abcam) was
purified with slight modifications18. Solutions of monomeric Aβ42 were prepared
by dissolving the lyophilized Aβ42 peptide in 6M GuHCl and then purifying
the peptide using a Superdex 75 10/300 GL column (GE Healthcare Bio-Sciences
AB SE-751 84). The centre of the elution peak was collected, and the peptide
concentration was determined from the absorbance of the integrated peak area
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using ε280= 1490 L/molcm. Aliquots of monomeric Aβ42 were diluted with
SSPE buffer to a concentration of 2 µM in low-binding Eppendorf tubes on ice.
Individual samples were then pipetted into multiple wells of a 96-well half-area
plate (Corning 3881) and the plate was placed into an incubator at 37 °C, under
quiescent conditions. Aliquots for measurements were then taken at ~15 min
(early aggregates) and ~30 min (late aggregates) after the plate was placed in the
incubator.
Single vesicle based membrane permeabilization assay. Vesicles with average
diameter of 200 nm were prepared by five freeze and thaw cycles combined with
extrusion as previously described19. Briefly, 16:0–18:1 PC (10 mg/mL) and
18:1–12:0 Biotin PC (1 mg/mL) (Avanti Lipids) were mixed with 100:1 ratio. The
lipid mixture was then hydrated in HEPES buffer (50 mM, pH 6.5) with 100 µM
Cal-520 (Stratech). Freeze and thaw cycles were performed using a water bath and
dry ice to get the unilamellarity. The lipid solution was extruded at least for 10
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Fig. 5 Single-particle characterization of the dye-labelled Aß42 aggregates, a Schematic representation of the separation workflow of the Aβ42 aggregates:
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triangles in the graph). The aggregated mixture collected at different time points was then loaded onto a sucrose step gradient that is divided into five
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increasing sucrose concentrations shifts towards higher FRET efficiencies indicates that size of the aggregates present in sucrose solution increases.
Relative FRET efficiency for each sucrose concentration are fitted with Gaussian function (solid lines) to get the maxima (shown in parenthesis).
d Schematic of the TIRF imaging for single-aggregate imaging. e Images of aggregates present in all five fractions are shown to represent the sizes detected
through TIRF microscopy and are representative of the indicated fractions. The scale bar is 3 µm. The FRET histograms of the fractions show a clear shift
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times through a membrane with a size cut off of 200 nm and size of the vesicles
were measure using a Zetasizer (Zetasizer Nano ZSP). Free dyes were removed
using size exclusion chromatography.
The single vesicle based assay was used to measure the permeability of lipid
bilayers in presence of toxic protein aggregates19,49. Glass cover slides (VWR
International, product number 63 1-0122) were cleaned by sonicating in 2% (v/v)
Hellmanex III (Hellma GmbH & Co. KG) in milliQ water for 10 min followed by
sonicating twice in milliQ water and in methanol for 10 min each. Then the cover
slides were dried under a stream of nitrogen gas, and plasma-etched using an argon
plasma cleaner (PDC-002, Harrick Plasma) for at least 30 min to remove any
fluorescent impurities. Each cover slide was fixed by frame-seal incubation
chambers (Biorad, Hercules) and the surface was coated with 100:1 PLL-g-PEG and
PLL-g-PEG biotin (SuSoS AG) (1 g/L) in 50 mM HEPES buffer. Then the cover
slides were washed three times and 0.1 mg/mL neutravidin (Thermo Scientific)
solution was added to the cover slide and incubated for 15 min and washed three
times with reaction buffer. Then, a 50 µL aliquot of the solution of purified
biotinylated vesicles was added to the cover slide and incubated for 30 min before
washing carefully at least five times with reaction buffer. Single vesicles tethered
to borosilicate glass cover slides via biotin neutravidin linkage were incubated
with 50 µL Ca2+ containing buffer solution Leibovitz’s L-15 (phenol red free) and
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Representative experiments showing the concentration of each antibody (x-axis) added to aggregates present in solutions at b and d 20% and c and e 30%
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(d, e). Antibodies that target C-terminal regions of Aβ42 are more effective at reducing the membrane permeability induced by Aβ42 aggregates.
Antibodies that target N-terminal regions of Aβ42 are more potent in reducing the inflammatory response induced by Aβ42 aggregates (d, e). As a positive
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background image was recorded (Fbackground). Thereafter, 50 µL of sample was
added and images were acquired (Fsample) and care was taken to avoid moving the
glass cover slides during the addition of each sample. Next, 10 µL of a solution
containing 1 mg/mL of ionomycin, an ionophore for Ca2+ ion, and subsequently
images of Ca2+ saturated single vesicles in the same fields of view were acquired
(Fionomycin). For each field of view 50 images were taken with an exposure time of
50 ms. The fields of view were chosen using an automated programme (homemade
bean-shell script, Micromanager) to avoid any user bias, which can be available
upon reasonable request. The relative influx of Ca2+ into an individual vesicle due
to aggregates of Aβ42 was then determined as
Ca2þinflux ¼ Fsample  Fbackground
FIonomycin  Fbackground
: ð1Þ
The average degree of was calculated by averaging the Ca2+ influx into
individual vesicles. Where representative data set is shown, all data sets show
similar qualitative trends. The sucrose fractions were diluted 1:10 for all
experiments in order to be in the linear regime of the measurement.
TIRF microscopy. Imaging was performed using a homebuilt TIRFM microscope
based on an inverted Nikon Ti microscope using a 488 nm laser for membrane
permeabilization assay35. The expanded and collimated laser beams were focused
onto the back-focal plane of the ×60, 1.49 NA oil immersion objective lens
(APON60XO TIRF, Olympus, product number N2709400). The fluorescence sig-
nal emerged from the sample was collected by the same objective and was sepa-
rated from the excitation beam by a dichroic (Di01-R405/488/561/635). The
emitted light was passed through an appropriate set of filters (for single vesicle
assay BLP01-488R, Semrock and FF01-520/44-25) to remove any unwanted light.
The fluorescence signal was then expanded 2.5 times and imaged onto a 512 × 512
pixel EMCCD camera (Photometrics Evolve, E VO-512-M-FW- 16-AC-110). The
open source software Micro Manager 1.4 was used to control the microscope
hardware and image acquisition50. Images were acquired in an unbiased way using
bean-shell based script.
Hydrophobicity mapping of individual Aβ42 aggregates. Argon plasma cleaned
glass coverslips were affixed to frame-seal slide chambers. They were then coated
with poly-L-lysine solution and incubated for 30 min and then washed three times
with filtered phosphate-buffered saline (PBS) buffer. Then aggregated Aβ42 present
in sucrose fraction was added to the coverslips and incubated for 20 min before
imaging using spectrally resolved PAINT42. The imaging was done using through
objective (Plan Apochromat ×60 NA 1.49; Olympus) TIRF mode. A 532 nm solid
state laser was used to excite the Nile red dye and the emitted fluorescence was
passed through a dichroic mirror (Di02-R532-25 × 36) and a bandpass filter (F01-
650/200-25). Nile red were dissolved into dimethyl sulfoxide to make a stock
solution and then diluted using filtered PBS buffer to a final concentration of 1 nM
for imaging. To obtain spectrally resolved images, a physical aperture (VA100/M;
Thorlabs) which acts as slit and a transmission diffraction grating (300 grooves/
mm; Thorlabs) were mounted just before the emCCD camera. Spectral calibration
was performed using Tetra spec beads (Life Technologies).
Separation of Aβ42 aggregates using sucrose gradients. Aliquots of the
aggregation reaction mixture of Aβ42 carried out in the absence of agitation were
sampled at three different time points: (i) after 15 min (the end of the lag phase),
(ii) after 30 min (the midpoint of the growth phase) and (iii) after 60 min (in the
plateau phase). The samples collected from the different time points were mixed
together and 400 µL aliquots were injected into a sucrose step gradient (10–50%
with 10% increment w/v in SSPE buffer). The sucrose density in a given solution
was determined by measurement of its refractive index. The sucrose solutions were
centrifuged for 15 h at 24.696g in an SW 60 Ti swinging-bucket rotor (Beckmann)
at room temperature. The fractions were collected immediately and stored on ice
until required.
Atomic force microscopy imaging of single aggregates. AFM studies were
performed on freshly cleaved mica substrates. Ten microlitres aliquots of each
diluted sample were deposited on the substrate at room temperature, incubated for
10 min, rinsed with 1 mL water, and then dried under a gentle flow of nitrogen gas.
AFM maps were generated by means of a NX10 (Park Systems, South Korea) and
JPK nanowizard2 system (JPK Instruments, Germany) operating in tapping mode
and equipped with a silicon tip with a nominal radius of <10 nm. Image flattening
and single-aggregate statistical analysis was performed by (Scanning Probe Image
Processor) SPIP software (Image Metrology, Denmark). While the geometry of the
AFM tip does not strongly affect the measurement of the height of an observed
object, it is the primary determinant of the lateral resolution. Indeed, a tip with an
apical radius of the same size, or larger than the dimensions of the object under
investigation, will affect the measurement of the diameter because of the so-called
convolution effect, resulting in an enlargement of the lateral dimensions. In the
present experiments, objects with typical lateral dimensions within 0.3–10 nm were
measured by a tip radius of approximately 10 nm. For this reason, we quantified
the deconvoluted diameter of the aggregates51. The level of experimental noise
(surface roughness plus electrical noise) for each image was measured using SPIP
software. It was well below 1 Å, leading to a signal to noise ratio ranging between
8 and 30. This allowed the cross-sectional height of individual objects within an
AFM map as small as a monomer to be determined with high sensitivity and
accuracy.
Aggregation of dye-labelled Aβ42. Monomeric Aβ42-labelled N-terminally with
HiLyte™ Fluor 647 and HiLyte™ Fluor 488 were purchased from AnaSpec. Mono-
meric Aβ42 solutions were prepared by dissolving the labelled peptides in 10 mM
NaOH at high concentration and then purified using a Bio-Sep 2000 HPLC
column (Phenomenex) in SSPE buffer. Peak fractions were collected, and the
peptide concentration was determined using the absorbance of the fluorescent
label with an extinction coefficient of 250,000M−1 cm−1 for HiLyte™ Fluor 647
and 70,000M−1 cm−1 for HiLyte™ Fluor 488. Monomeric fractions were frozen
immediately after size exclusion and kept at −80 °C until further use. For aggre-
gation, aliquots of labelled monomeric Aβ42 were diluted to an equimolar
concentration of 2 µM of HiLyte647 Aβ42 and HiLyte488 Aβ42 in low-binding
Eppendorf tubes and incubated at 37 °C in SSPE buffer for aggregation under
quiescent conditions.
Single-molecule confocal FRET measurements. Centrifuged samples were
separated, and each aliquot were taken and diluted to nanomolar concentrations in
buffer. Diluted protein samples were withdrawn through a single-channel micro-
fluidic device (width= 100 µm, height= 25 µm, length= 1 cm), at a flow velocity
of 50 µL/h to a syringe via polyethylene tubing. Single-molecule confocal FRET
experiments were performed on the instrument described by Li et al.52. by use of
the 488 nm laser (1.5 mW) only. In brief, a 488 nm laser beam was directed to the
back aperture of an inverted microscope (Nikon Eclipse TE2000-U) through a high
numerical aperture oil immersion objective (Apochromat ×60, NA 1.40; Nikon).
Fluorescence was directed onto a 50-μm pinhole, and then separated in two
different channels by using a dichroic mirror (585DRLP; Omega Filters) and sent
to two avalanche photodiodes (APD) (SPCM AQR-14; Perkin–Elmer Optoelec-
tronics). For all of the single-molecule experiments, data were collected at 20 °C.
A custom-programmed field-programmable gate array (Colexica) was used to
count the signals from the APD and combine these into time bins. These were
selected according to the expected residence time of molecules passing through
the confocal probe volume. For each sample, data were collected for 10 min
(100,000 time bins, bin width 0.2 ms). Confocal FRET data analysis was done using
custom written software in IgorPro (wavemetrics)53.
Single-aggregate imaging with Thioflavin-T (ThT). To check if the aggregates of
the Aβ42 peptide disaggregate in the presence of DesAbs, we have performed ThT
based single-aggregate imaging using TIRF microscopy41. Glass coverslips were
cleaned using an argon-based plasma cleaner and incubated with poly-(L)-lysine
solution for 30 min for surface coating. Then Aβ42 aggregates only or Aβ42
aggregates and DesAbs were mixed with 10 µM ThT and added to the coverslips.
The solution was incubated on the coverslip for 20 min to ensure attachment to the
surface. For each sample nine different fields of view, which were selected in an
unbiased way, were imaged. Each image was recorded at 100 ms exposure and
100 frames for each field of view. The number of ThT-active spots was calculated
using ImageJ using constant noise tolerance for all the datasets.
Design and production of the rationally designed antibodies. Rationally
designed antibodies (DesAbs) were generated using previously described proce-
dure15. Briefly, complementary peptides were selected using the cascade method14
to target linear epitopes within Aβ42 that scan its entire sequence. These com-
plementary peptides were then grafted into the CDR3 of the DesAb scaffold by
means of a mutagenic polymerase chain reaction with phosphorylated oligonu-
cleotides (Supplementary Table 1). The DesAbs were then expressed and purified
using the pRSET-B vector in Rosetta-gami 2 (DE3) (Merck Millipore). Cells were
grown at 30 °C with shaking at 180 r.p.m. for 15 h using Overnight Express Instant
TB Medium (Merck Millipore) supplemented with 100 μg/mL ampicillin. They
were harvested, re-suspended in phosphate-buffered saline (PBS) supple-
mented with one tablet of EDTA-Free Complete Protease Inhibitor Cocktail
(Roche) per 500 mL of cell growth, and lysed by sonication. Cell debris were
removed by centrifugation at 15,000 r.p.m. (JA-20 rotor; Beckman Coulter) and the
cleared supernatant was loaded onto a Ni2+-NTA Superflow column (Qiagen),
previously equilibrated using PBS containing 10 mM imidazole. The column was
then washed with PBS containing 40 mM imidazole. Finally, His-tagged DesAbs
were eluted with PBS containing 200 mM imidazole. Imidazole was then removed
using size exclusion chromatography with a HiLoad 16/600 Superdex 75 pg column
(GE Healthcare). Protein concentration was determined by absorbance measure-
ment at 280 nm using theoretical extinction coefficients calculated with ExPASy
ProtParam. All the DesAbs used in this study are available from the author upon
reasonable request.
Cell cultures. The BV2 cell line (RRID:CVCL_0182) was derived from immorta-
lized murine neonatal microglia. They were grown in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% foetal bovine serum and 1% L-gluta-
mine (Life Technologies) and incubated at 37 °C in a humidified atmosphere of 5%
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CO2 and 95% air, until a density was reached of approximately 1.6 × 106 cell/mL.
All sucrose fractions were diluted 1:5 and added to the BV2 cells to perform the
inflammatory assays. No significant cell death was observed over 24 h in any
experiment.
ELISA assays. To determine cumulative TNF-α production, samples of super-
natant were obtained after incubation of BC2 cells with early and late soluble
aggregates of Aβ42 over 24 h and stored at −80 °C until analysed28. TNF-α was
analysed using the Duoset® enzyme-linked immunosorbent assay (ELISA) devel-
opment system (R&D Systems, Abingdon, Oxfordshire, UK). Three wells were
used in each experiment to estimate error bars. RSLA was obtained from
InvivoGen.
Statistical tests. To assess the statistical significance of the difference in the early
and late aggregate-induced membrane permeability and inflammation, we per-
formed two-sample t-test (unpaired) with three biological replicates (Fig. 1c, e)
using origin 9.0. To determine if the inhibition of toxicity by the C-terminally
binding antibody (DesAB 3–9) and N-terminally binding antibody (DesAb 36–42)
are different, we also performed two-sample t-test (unpaired) at the highest anti-
body concentration using nine different fields of view (for membrane permeability
assay) or three different wells (for the inflammation assay).
Data availability
Data supporting the findings of this manuscript are available from the corresponding
authors upon reasonable request. A reporting summary for this article is available as a
Supplementary Information file. The source data underlying Figs. 1, 2, 4, 5, 6 and
Supplementary Figs. 1, 2, 3, 4, 6, 7 are provided as a Source Data file.
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